Oral PCSK9 Inhibitor Slashed Cholesterol
(MedPage Today) -- People with high LDL cholesterol already on statin therapy were able to reduce their levels by as much as 65% with MK-0616, an investigative oral PCSK9 inhibitor, a researcher reported at the American Heart Association (AHA...
Read more »